The DOI matches its Crossref record; 381 of the 381 references it cites were found in a registry or an index.
Clinical and Molecular Genetics of the Phosphodiesterases (PDEs)
Open accessAbstract
Cyclic nucleotide phosphodiesterases (PDEs) are enzymes that have the unique function of terminating cyclic nucleotide signaling by catalyzing the hydrolysis of cAMP and GMP. They are critical regulators of the intracellular concentrations of cAMP and cGMP as well as of their signaling pathways and downstream biological effects. PDEs have been exploited pharmacologically for more than half a century, and some of the most successful drugs worldwide today affect PDE function. Recently, mutations in PDE genes have been identified as causative of certain human genetic diseases; even more recently, functional variants of PDE genes have been suggested to play a potential role in predisposition to tumors and/or cancer, especially in cAMP-sensitive tissues. Mouse models have been developed that point to wide developmental effects of PDEs from heart function to reproduction, to tumors, and beyond. This review brings together knowledge from a variety of disciplines (biochemistry and pharmacology, oncology, endocrinology, and reproductive sciences) with emphasis on recent research on PDEs, how PDEs affect cAMP and cGMP signaling in health and disease, and what pharmacological exploitations of PDEs may be useful in modulating cyclic nucleotide signaling in a way that prevents or treats certain human diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Baillie, G. S., Sood, A., McPhee, I., Gall, I., Perry, S. J., Lefkowitz, R. J., & Houslay, M. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262787199 · Cited by 360
RetractedLynch, M. J., Baillie, G. S., Mohamed, A., Li, X., Maisonneuve, C., Klussmann, E., van Heeke, G., & Houslay, M. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414316200 · Cited by 206
RetractedDerrien, T., Johnson, R., Bussotti, G., Tanzer, A., Djebali, S., Tilgner, H., Guernec, G., Martin, D., Merkel, A., Knowles, D. G., et al. (2012) · Genome Research · doi:10.1101/gr.132159.111 · Cited by 5,061
Cardiac excitation–contraction coupling
Bers, D. M. (2002) · Nature · doi:10.1038/415198a · Cited by 4,744
A gene atlas of the mouse and human protein-encoding transcriptomes
Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400782101 · Cited by 3,475
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension
Galiè, N., Ghofrani, H. A., Torbicki, A., Barst, R. J., Rubin, L. J., Badesch, D., Fleming, T., Parpia, T., Burgess, G., Branzi, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050010 · Cited by 2,476
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
Packer, M., Carver, J. R., Rodeheffer, R. J., Ivanhoe, R. J., DiBianco, R., Zeldis, S. M., Hendrix, G. H., Bommer, W. J., Elkayam, U., Kukin, M. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252103 · Cited by 2,225
Adenosine 3‘,5‘-Phosphate in Biological Materials
Butcher, R. W., & Sutherland, E. W. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60316-3 · Cited by 2,077
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
Bender, A. T., & Beavo, J. A. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.5 · Cited by 1,781
Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
Beavo, J. A. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.4.725 · Cited by 1,767
The evolution of gene expression levels in mammalian organs
Brawand, D., Soumillon, M., Necsulea, A., Julien, P., Csárdi, G., Harrigan, P., Weier, M., Liechti, A., Aximu-Petri, A., Kircher, M., et al. (2011) · Nature · doi:10.1038/nature10532 · Cited by 1,248
Conti, M., & Beavo, J. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060305.150444 · Cited by 1,183
Cyclic Nucleotide-Gated Ion Channels
Kaupp, U. B., & Seifert, R. (2002) · Physiological Reviews · doi:10.1152/physrev.00008.2002 · Cited by 1,143
Tadalafil Therapy for Pulmonary Arterial Hypertension
Galiè, N., Brundage, B. H., Ghofrani, H. A., Oudiz, R. J., Simonneau, G., Safdar, Z., Shapiro, S., White, R. J., Chan, M., Beardsworth, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.839274 · Cited by 1,103
FRACTIONATION AND CHARACTERIZATION OF A CYCLIC ADENINE RIBONUCLEOTIDE FORMED BY TISSUE PARTICLES
Sutherland, E. W., & Rall, T. W. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77423-7 · Cited by 1,076
The Evolutionary Landscape of Alternative Splicing in Vertebrate Species
Barbosa-Morais, N. L., Irimia, M., Pan, Q., Xiong, H. Y., Gueroussov, S., Lee, L. J., Slobodeniuc, V., Kutter, C., Watt, S., Çolak, R., et al. (2012) · Science · doi:10.1126/science.1230612 · Cited by 1,063
Cyclic nucleotide research — still expanding after half a century
Beavo, J. A., & Brunton, L. L. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm911 · Cited by 903
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
Takimoto, E., Champion, H. C., Li, M., Belardi, D., Ren, S., Rodriguez, E. R., Bedja, D., Gabrielson, K. L., Wang, Y., & Kass, D. A. (2005) · Nature Medicine · doi:10.1038/nm1175 · Cited by 903
Lugnier, C. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.07.003 · Cited by 870
Bowes, C., Li, T., Danciger, M., Baxter, L. C., Applebury, M. L., & Farber, D. B. (1990) · Nature · doi:10.1038/347677a0 · Cited by 852
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
Calverley, P. M., Rabe, K. F., Goehring, U.-M., Kristiansen, S., Fabbri, L. M., & Martinez, F. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61255-1 · Cited by 829
Overview of PDEs and Their Regulation
Omori, K., & Kotera, J. (2007) · Circulation Research · doi:10.1161/01.res.0000256354.95791.f1 · Cited by 796
Serafini, P., Meckel, K., Kelso, M., Noonan, K., Califano, J., Koch, W., Dolcetti, L., Bronte, V., & Borrello, I. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061104 · Cited by 766
Wehrens, X. H. T., Lehnart, S. E., Huang, F., Vest, J. A., Reiken, S. R., Mohler, P. J., Sun, J., Guatimosim, S., Song, L.-S., Rosemblit, N., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00434-3 · Cited by 764
HOUSLAY, M. D., & ADAMS, D. R. (2003) · Biochemical Journal · doi:10.1042/bj20021698 · Cited by 763
Novel domains of the prokaryotic two-component signal transduction systems
Galperin, M. (2001) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(01)00326-3 · Cited by 665
DISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling
Millar, J. K., Pickard, B. S., Mackie, S., James, R., Christie, S., Buchanan, S. R., Malloy, M. P., Chubb, J. E., Huston, E., Baillie, G. S., et al. (2005) · Science · doi:10.1126/science.1112915 · Cited by 648 · cited 1×
“For instance, PDE4B abnormalities have been linked to schizophrenia (12), whereas defects in PDE6 subunits cause hereditary eye diseases (13, 14).”
BackgroundPotter, L. R., Yoder, A. R., Flora, D. R., Antos, L. K., & Dickey, D. M. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-68964-5_15 · Cited by 647
Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions
Francis, S. H., Blount, M. A., & Corbin, J. D. (2011) · Physiological Reviews · doi:10.1152/physrev.00030.2010 · Cited by 639
Keynote review: Phosphodiesterase-4 as a therapeutic target
Houslay, M. D., Schafer, P., & Zhang, K. Y. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03622-6 · Cited by 635
Pituitary Adenoma Predisposition Caused by Germline Mutations in the AIP Gene
Vierimaa, O., Georgitsi, M., Lehtonen, R., Vahteristo, P., Kokko, A., Raitila, A., Tuppurainen, K., Ebeling, T. M. L., Salmela, P. I., Paschke, R., et al. (2006) · Science · doi:10.1126/science.1126100 · Cited by 618
AKAPs: from structure to function
Colledge, M., & Scott, J. D. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01558-5 · Cited by 611
McLaughlin, M. E., Sandberg, M. A., Berson, E. L., & Dryja, T. P. (1993) · Nature Genetics · doi:10.1038/ng0693-130 · Cited by 596
Cyclic nucleotide phosphodiesterases: Relating structure and function
Francis, S. H., Turko, I. V., & Corbin, J. D. (2000) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(00)65001-8 · Cited by 564
The gene encoding phosphodiesterase 4D confers risk of ischemic stroke
Gretarsdottir, S., Thorleifsson, G., Reynisdottir, S. T., Manolescu, A., Jonsdottir, S., Jonsdottir, T., Gudmundsdottir, T., Bjarnadottir, S. M., Einarsson, O. B., Gudjonsdottir, H. M., et al. (2003) · Nature Genetics · doi:10.1038/ng1245 · Cited by 564
The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways
Dodge-Kafka, K. L., Soughayer, J., Pare, G. C., Carlisle Michel, J. J., Langeberg, L. K., Kapiloff, M. S., & Scott, J. D. (2005) · Nature · doi:10.1038/nature03966 · Cited by 556
Epac proteins: multi-purpose cAMP targets
Bos, J. L. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.10.002 · Cited by 532
Lehnart, S. E., Wehrens, X. H. T., Reiken, S., Warrier, S., Belevych, A. E., Harvey, R. D., Richter, W., Jin, S.-L. C., Conti, M., & Marks, A. R. (2005) · Cell · doi:10.1016/j.cell.2005.07.030 · Cited by 517
Cyclic GMP from the surrounding somatic cells regulates cyclic AMP and meiosis in the mouse oocyte
Norris, R. P., Ratzan, W. J., Freudzon, M., Mehlmann, L. M., Krall, J., Movsesian, M. A., Wang, H., Ke, H., Nikolaev, V. O., & Jaffe, L. A. (2009) · Development · doi:10.1242/dev.035238 · Cited by 516
Lincoln, T. M., Dey, N., & Sellak, H. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.3.1421 · Cited by 510
Targeting of Cyclic AMP Degradation to β 2 -Adrenergic Receptors by β-Arrestins
Perry, S. J., Baillie, G. S., Kohout, T. A., McPhee, I., Magiera, M. M., Ang, K. L., Miller, W. E., McLean, A. J., Conti, M., Houslay, M. D., et al. (2002) · Science · doi:10.1126/science.1074683 · Cited by 506
cAMP-GEFII is a direct target of cAMP in regulated exocytosis
Ozaki, N., Shibasaki, T., Kashima, Y., Miki, T., Takahashi, K., Ueno, H., Sunaga, Y., Yano, H., Matsuura, Y., Iwanaga, T., et al. (2000) · Nature Cell Biology · doi:10.1038/35041046 · Cited by 481 · cited 1×
“Downstream of Rap, a variety of effectors have been implicated in the control of a variety of processes, including integrin-mediated cell adhesion and cell-cell junction formation (22), exocytosis (28–30), insulin secretion (31), and cardiomyocyte function (32).”
BackgroundCyclic AMP-specific PDE4 Phosphodiesterases as Critical Components of Cyclic AMP Signaling
Conti, M., Richter, W., Mehats, C., Livera, G., Park, J.-Y., & Jin, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r200029200 · Cited by 481
Rabe, K. F., Bateman, E. D., O'Donnell, D., Witte, S., Bredenbröker, D., & Bethke, T. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67100-0 · Cited by 475
Multiple cyclic nucleotide phosphodiesterases.
Beavo, J. A., Conti, M., & Heaslip, R. J. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09714-7 · Cited by 472
Nitric Oxide Signaling in Brain Function, Dysfunction, and Dementia
Steinert, J. R., Chernova, T., & Forsythe, I. D. (2010) · The Neuroscientist · doi:10.1177/1073858410366481 · Cited by 469
Patrucco, E., Notte, A., Barberis, L., Selvetella, G., Maffei, A., Brancaccio, M., Marengo, S., Russo, G., Azzolino, O., Rybalkin, S. D., et al. (2004) · Cell · doi:10.1016/j.cell.2004.07.017 · Cited by 468
Tailoring cAMP-signalling responses through isoform multiplicity
Houslay, M. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01050-5 · Cited by 439
Theophylline: New Perspectives for an Old Drug
Barnes, P. J. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1142pp · Cited by 435
Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown
Houslay, M. D. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.09.007 · Cited by 430
Structure, Localization, and Regulation of cGMP-inhibited Phosphodiesterase (PDE3)
Degerman, E., Belfrage, P., & Manganiello, V. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.6823 · Cited by 428
Self-citationHistorical review: A brief history and personal retrospective of seven-transmembrane receptors
Lefkowitz, R. J. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.06.006 · Cited by 417
Sette, C., & Conti, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16526 · Cited by 409
Boswell‐Smith, V., Spina, D., & Page, C. P. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706495 · Cited by 405
Fujishige, K., Kotera, J., Michibata, H., Yuasa, K., Takebayashi, S.-I., Okumura, K., & Omori, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18438 · Cited by 404
Burgin, A. B., Magnusson, O. T., Singh, J., Witte, P., Staker, B. L., Bjornsson, J. M., Thorsteinsdottir, M., Hrafnsdottir, S., Hagen, T., Kiselyov, A. S., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1598 · Cited by 397
Keravis, T., & Lugnier, C. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01729.x · Cited by 385
Novel signaling mechanisms in the ovary during oocyte maturation and ovulation
Conti, M., Hsieh, M., Musa Zamah, A., & Oh, J. S. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.11.002 · Cited by 383
Guazzi, M., Vicenzi, M., Arena, R., & Guazzi, M. D. (2011) · Circulation: Heart Failure · doi:10.1161/circheartfailure.110.944694 · Cited by 382
Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A
Soderling, S. H., Bayuga, S. J., & Beavo, J. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.7071 · Cited by 374
Physiological Substrates of cAMP-Dependent Protein Kinase
Shabb, J. B. (2001) · Chemical Reviews · doi:10.1021/cr000236l · Cited by 373
Jin, S.-L. C., & Conti, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122041599 · Cited by 367
Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A
Fawcett, L., Baxendale, R., Stacey, P., McGrouther, C., Harrow, I., Soderling, S., Hetman, J., Beavo, J. A., & Phillips, S. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3702 · Cited by 359
Fisher, P. W., Salloum, F., Das, A., Hyder, H., & Kukreja, R. C. (2005) · Circulation · doi:10.1161/01.cir.0000160359.49478.c2 · Cited by 355
Horvath, A., Boikos, S., Giatzakis, C., Robinson-White, A., Groussin, L., Griffin, K. J., Stein, E., Levine, E., Delimpasi, G., Hsiao, H. P., et al. (2006) · Nature Genetics · doi:10.1038/ng1809 · Cited by 352
Self-citationMaurice, D. H., & Haslam, R. J. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10974-7 · Cited by 351
Gene expression analyses reveal molecular relationships among 20 regions of the human CNS
Roth, R. B., Hevezi, P., Lee, J., Willhite, D., Lechner, S. M., Foster, A. C., & Zlotnik, A. (2006) · Neurogenetics · doi:10.1007/s10048-006-0032-6 · Cited by 342
Isolation of adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate from rat urine
Ashman, D. F., Lipton, R., Melicow, M. M., & Price, T. D. (1963) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(63)90566-7 · Cited by 341
Isolation and Characterization of PDE9A, a Novel Human cGMP-specific Phosphodiesterase
Fisher, D. A., Smith, J. F., Pillar, J. S., Denis, S. H. S., & Cheng, J. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15559 · Cited by 341
PDE4 inhibitors: current status
Spina, D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.307 · Cited by 340
Immunohistochemical localization of PDE10A in the rat brain
Seeger, T. F., Bartlett, B., Coskran, T. M., Culp, J. S., James, L. C., Krull, D. L., Lanfear, J., Ryan, A. M., Schmidt, C. J., Strick, C. A., et al. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02754-9 · Cited by 334
Das, A., Xi, L., & Kukreja, R. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404706200 · Cited by 333
Boess, F. G., Hendrix, M., van der Staay, F.-J., Erb, C., Schreiber, R., van Staveren, W., de Vente, J., Prickaerts, J., Blokland, A., & Koenig, G. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.040 · Cited by 330
Daly, A. F., Vanbellinghen, J.-F., Khoo, S. K., Jaffrain-Rea, M.-L., Naves, L. A., Guitelman, M. A., Murat, A., Emy, P., Gimenez-Roqueplo, A.-P., Tamburrano, G., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2513 · Cited by 326
Effect of 1-Year Treatment with Roflumilast in Severe Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Sanchez-Toril, F., McIvor, A., Teichmann, P., Bredenbroeker, D., & Fabbri, L. M. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200610-1563oc · Cited by 325
Porst, H., Padma-Nathan, H., Giuliano, F., Anglin, G., Varanese, L., & Rosen, R. (2003) · Urology · doi:10.1016/s0090-4295(03)00359-5 · Cited by 320
Houslay, M. D., Baillie, G. S., & Maurice, D. H. (2007) · Circulation Research · doi:10.1161/01.res.0000261934.56938.38 · Cited by 317
Bolger, G., Michaeli, T., Martins, T., St John, T., Steiner, B., Rodgers, L., Riggs, M., Wigler, M., & Ferguson, K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6558 · Cited by 315
Vaccari, S., Weeks, J. L., Hsieh, M., Menniti, F. S., & Conti, M. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.109.077768 · Cited by 308
Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4)
O'Donnell, J. M., & Zhang, H.-T. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.01.003 · Cited by 307
Leontiou, C. A., Gueorguiev, M., van der Spuy, J., Quinton, R., Lolli, F., Hassan, S., Chahal, H. S., Igreja, S. C., Jordan, S., Rowe, J., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2611 · Cited by 299
Ockaili, R., Salloum, F., Hawkins, J., & Kukreja, R. C. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00324.2002 · Cited by 292
Houslay, M. D., Sullivan, M., & Bolger, G. B. (1998) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60128-3 · Cited by 290
Ghofrani, H. A., Voswinckel, R., Reichenberger, F., Olschewski, H., Haredza, P., Karadaş, B., Schermuly, R. T., Weissmann, N., Seeger, W., & Grimminger, F. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.06.060 · Cited by 286
The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding
Martinez, S. E., Wu, A. Y., Glavas, N. A., Tang, X.-B., Turley, S., Hol, W. G. J., & Beavo, J. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192374899 · Cited by 286
Identification and Characterization of a Novel Family of Cyclic Nucleotide Phosphodiesterases
Soderling, S. H., Bayuga, S. J., & Beavo, J. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15553 · Cited by 283
Mongillo, M., Tocchetti, C. G., Terrin, A., Lissandron, V., Cheung, Y.-F., Dostmann, W. R., Pozzan, T., Kass, D. A., Paolocci, N., Houslay, M. D., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000200178.34179.93 · Cited by 278
Guanylyl cyclase structure, function and regulation
Potter, L. R. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.09.001 · Cited by 274
Rabe, K. F. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01218.x · Cited by 273
Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase
Soderling, S. H., Bayuga, S. J., & Beavo, J. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8991 · Cited by 271
Hoffmann, R., Baillie, G. S., MacKenzie, S. J., Yarwood, S. J., & Houslay, M. D. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.893 · Cited by 270
Grauer, S. M., Pulito, V. L., Navarra, R. L., Kelly, M. P., Kelley, C., Graf, R., Langen, B., Logue, S., Brennan, J., Jiang, L., et al. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155994 · Cited by 269
Selective phosphodiesterase inhibitors: a promising target for cognition enhancement
Reneerkens, O. A. H., Rutten, K., Steinbusch, H. W. M., Blokland, A., & Prickaerts, J. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1273-x · Cited by 266
Cyclic Nucleotide-Gated Channels
Biel, M., & Michalakis, S. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-68964-5_7 · Cited by 265
Singh, T. P., Rohit, M., Grover, A., Malhotra, S., & Vijayvergiya, R. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.09.006 · Cited by 263
Cyclic nucleotide phosphodiesterase 3A–deficient mice as a model of female infertility
Masciarelli, S., Horner, K., Liu, C., Park, S. H., Hinckley, M. D., Hockman, S. C., Nedachi, T., Jin, C., Conti, M., & Manganiello, V. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421804 · Cited by 261
Self-citationCD3- and CD28-Dependent Induction of PDE7 Required for T Cell Activation
Li, L., Yee, C., & Beavo, J. A. (1999) · Science · doi:10.1126/science.283.5403.848 · Cited by 259
Sakaba, T., & Neher, E. (2003) · Nature · doi:10.1038/nature01859 · Cited by 259
Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling
Mehats, C., Andersen, C. B., Filopanti, M., Jin, S.-L. C., & Conti, M. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00523-9 · Cited by 257
Review on plants with CNS-effects used in traditional South African medicine against mental diseases
Stafford, G. I., Pedersen, M. E., van Staden, J., & Jäger, A. K. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.08.010 · Cited by 254
Huang, S. H., Pittler, S. J., Huang, X., Oliveira, L., Berson, E. L., & Dryja, T. P. (1995) · Nature Genetics · doi:10.1038/ng1295-468 · Cited by 253
Pharmacotherapy for Erectile Dysfunction
Eardley, I., Donatucci, C., Corbin, J., El-Meliegy, A., Hatzimouratidis, K., McVary, K., Munarriz, R., & Lee, S. W. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01627.x · Cited by 252
Mechanisms of action of PDE5 inhibition in erectile dysfunction
Corbin, J. D. (2004) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901205 · Cited by 246
Gal, A., Orth, U., Baehr, W., Schwinger, E., & Rosenberg, T. (1994) · Nature Genetics · doi:10.1038/ng0594-64 · Cited by 246
Hayes, J. S., Brunton, L. L., & Mayer, S. E. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70757-1 · Cited by 241
Vinpocetine inhibits NF-κB–dependent inflammation via an IKK-dependent but PDE-independent mechanism
Jeon, K.-I., Xu, X., Aizawa, T., Lim, J. H., Jono, H., Kwon, D.-S., Abe, J.-I., Berk, B. C., Li, J.-D., & Yan, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914414107 · Cited by 241
Salloum, F., Yin, C., Xi, L., & Kukreja, R. C. (2003) · Circulation Research · doi:10.1161/01.res.0000066853.09821.98 · Cited by 241
PDE4 cAMP-specific phosphodiesterases
Houslay, M. D. (2001) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(01)69049-4 · Cited by 239
PDE5 is converted to an activated state upon cGMP binding to the GAF A domain
Rybalkin, S. D. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg051 · Cited by 234
Siuciak, J. A., McCarthy, S. A., Chapin, D. S., Fujiwara, R. A., James, L. C., Williams, R. D., Stock, J. L., McNeish, J. D., Strick, C. A., Menniti, F. S., et al. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.01.012 · Cited by 231
Pérez-Torres, S., Miró, X., Palacios, J. M., Cortés, R., Puigdoménech, P., & Mengod, G. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00097-1 · Cited by 229
Mizuno, T., Kurotani, T., Komatsu, Y., Kawanokuchi, J., Kato, H., Mitsuma, N., & Suzumura, A. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.009 · Cited by 228
Phosphodiesterase Type 5 Inhibitors for Pulmonary Arterial Hypertension
Archer, S. L., & Michelakis, E. D. (2009) · New England Journal of Medicine · doi:10.1056/nejmct0904473 · Cited by 224
Protein Kinase A Type I and Type II Define Distinct Intracellular Signaling Compartments
Di Benedetto, G., Zoccarato, A., Lissandron, V., Terrin, A., Li, X., Houslay, M. D., Baillie, G. S., & Zaccolo, M. (2008) · Circulation Research · doi:10.1161/circresaha.108.174813 · Cited by 220
In vivo differential prenylation of retinal cyclic GMP phosphodiesterase catalytic subunits.
Anant, J. S., Ong, O. C., Xie, H. Y., Clarke, S., O'Brien, P. J., & Fung, B. K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48336-6 · Cited by 218
Loughney, K., Hill, T. R., Florio, V. A., Uher, L., Rosman, G. J., Wolda, S. L., A. Jones, B., Howard, M. L., McAllister-Lucas, L. M., Sonnenburg, W. K., et al. (1998) · Gene · doi:10.1016/s0378-1119(98)00303-5 · Cited by 218
Phosphodiesterase Type 5: Expanding Roles in Cardiovascular Regulation
Kass, D. A., Champion, H. C., & Beavo, J. A. (2007) · Circulation Research · doi:10.1161/circresaha.107.162511 · Cited by 217
Compartmentalisation of phosphodiesterases and protein kinase A: opposites attract
Baillie, G. S., Scott, J. D., & Houslay, M. D. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.089 · Cited by 209
Isolation and characterization of PDE10A, a novel human 3′, 5′-cyclic nucleotide phosphodiesterase
Loughney, K., Snyder, P. B., Uher, L., Rosman, G. J., Ferguson, K., & Florio, V. A. (1999) · Gene · doi:10.1016/s0378-1119(99)00171-7 · Cited by 208
Overview of phosphodiesterase 5 inhibition in erectile dysfunction
Rosen, R. C., & Kostis, J. B. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00824-5 · Cited by 205
McNamara, P. J., Laique, F., Muang-In, S., & Whyte, H. E. (2006) · Journal of Critical Care · doi:10.1016/j.jcrc.2006.01.001 · Cited by 201
Takimoto, E., Koitabashi, N., Hsu, S., Ketner, E. A., Zhang, M., Nagayama, T., Bedja, D., Gabrielson, K. L., Blanton, R., Siderovski, D. P., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35620 · Cited by 200
Integrating Cardiac PIP3 and cAMP Signaling through a PKA Anchoring Function of p110γ
Perino, A., Ghigo, A., Ferrero, E., Morello, F., Santulli, G., Baillie, G. S., Damilano, F., Dunlop, A. J., Pawson, C., Walser, R., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.01.030 · Cited by 200
PDE10A inhibition reverses subchronic PCP‐induced deficits in attentional set‐shifting in rats
Rodefer, J. S., Murphy, E. R., & Baxter, M. G. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03937.x · Cited by 199
Yan, C., Zhao, A. Z., Bentley, J. K., Loughney, K., Ferguson, K., & Beavo, J. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9677 · Cited by 195
Tsertsvadze, A., Fink, H. A., Yazdi, F., MacDonald, R., Bella, A. J., Ansari, M. T., Garritty, C., Soares-Weiser, K., Daniel, R., Sampson, M., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-9-200911030-00150 · Cited by 193
Mutation in PDE8B,a Cyclic AMP–Specific Phosphodiesterase in Adrenal Hyperplasia
Horvath, A., Mericq, V., & Stratakis, C. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0706182 · Cited by 190
Self-citationFujishige, K., Kotera, J., & Omori, K. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00963.x · Cited by 188
Recurrent PRKAR1A Mutation in Acrodysostosis with Hormone Resistance
Linglart, A., Menguy, C., Couvineau, A., Auzan, C., Gunes, Y., Cancel, M., Motte, E., Pinto, G., Chanson, P., Bougnères, P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012717 · Cited by 186
Riabowol, K. T., Fink, J. S., Oilman, M. Z., Walsh, D. A., Goodman, R. H., & Feramisco, J. R. (1988) · Nature · doi:10.1038/336083a0 · Cited by 185
Li, Y.-F., Huang, Y., Amsdell, S. L., Xiao, L., O'Donnell, J. M., & Zhang, H.-T. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.66 · Cited by 185
Ariga, M., Neitzert, B., Nakae, S., Mottin, G., Bertrand, C., Pruniaux, M. P., Jin, S.-L. C., & Conti, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7531 · Cited by 181
Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B–null mice
Choi, Y. H., Park, S., Hockman, S., Zmuda-Trzebiatowska, E., Svennelid, F., Haluzik, M., Gavrilova, O., Ahmad, F., Pepin, L., Napolitano, M., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24867 · Cited by 180
Self-citationResults of a Phase II Study of the Antidepressant Effect of Rolipram
Zeller, E., Stief, H., Pflug, B., & Sastre-y-Hernández, M. (1984) · Pharmacopsychiatry · doi:10.1055/s-2007-1017435 · Cited by 179
Sudo, T., Tachibana, K., Toga, K., Tochizawa, S., Inoue, Y., Kimura, Y., & Hidaka, H. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00346-9 · Cited by 177
The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents
van der Staay, F. J., Rutten, K., Bärfacker, L., DeVry, J., Erb, C., Heckroth, H., Karthaus, D., Tersteegen, A., van Kampen, M., Blokland, A., et al. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.005 · Cited by 177
Vardenafil in Pulmonary Arterial Hypertension: A Randomized, Double-blind, Placebo-controlled Study
Jing, Z.-C., Yu, Z.-X., Shen, J.-Y., Wu, B.-X., Xu, K.-F., Zhu, X.-Y., Pan, L., Zhang, Z.-L., Liu, X.-Q., Zhang, Y.-S., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0093oc · Cited by 175
Presynaptic Mechanism Underlying cAMP-Dependent Synaptic Potentiation
Kaneko, M., & Takahashi, T. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0999-04.2004 · Cited by 174
Wang, P., Wu, P., Ohleth, K. M., Egan, R. W., & Billah, M. M. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26397-5 · Cited by 173
Hebb, A. L. O., Robertson, H. A., & Denovan-Wright, E. M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.11.009 · Cited by 172
Baillie, G. S., MacKenzie, S. J., McPhee, I., & Houslay, M. D. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703636 · Cited by 170
Bolger, G. B., Peden, A. H., Steele, M. R., MacKenzie, C., McEwan, D. G., Wallace, D. A., Huston, E., Baillie, G. S., & Houslay, M. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303269200 · Cited by 168
Signal transduction by heme-containing PAS-domain proteins
Gilles-Gonzalez, M.-A., & Gonzalez, G. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00941.2003 · Cited by 167
Stangherlin, A., Gesellchen, F., Zoccarato, A., Terrin, A., Fields, L. A., Berrera, M., Surdo, N. C., Craig, M. A., Smith, G., Hamilton, G., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.230698 · Cited by 165
Signaling from β1- and β2-adrenergic receptors is defined by differential interactions with PDE4
Richter, W., Day, P., Agrawal, R., Bruss, M. D., Granier, S., Wang, Y. L., Rasmussen, S. G. F., Horner, K., Wang, P., Lei, T., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601968 · Cited by 164
Yan, C., Zhao, A. Z., Bentley, J. K., & Beavo, J. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.41.25699 · Cited by 164
Efficacy of Sildenafil Citrate (Viagra) in Men with Premature Ejaculation
McMahon, C. G., Stuckey, B. G. A., Andersen, M., Purvis, K., Koppiker, N., Haughie, S., & Boolell, M. (2005) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2005.20351.x · Cited by 163
Phototransduction: crystal clear
Ridge, K. D., Abdulaev, N. G., Sousa, M., & Palczewski, K. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00172-5 · Cited by 163
Baumer, W., Hoppmann, J., Rundfeldt, C., & Kietzmann, M. (2007) · Inflammation & Allergy-Drug Targets · doi:10.2174/187152807780077318 · Cited by 162
Phosphodiesterase type 5 inhibition improves early memory consolidation of object information
Prickaerts, J., Şık, A., van Staveren, W. C. G., Koopmans, G. C., Steinbusch, H. W. M., van der Staay, F. J., de Vente, J., & Blokland, A. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2004.03.022 · Cited by 162
Ke, H., & Wang, H. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607779941242 · Cited by 159
Lin, C.-S., Lau, A., Tu, R., & Lue, T. F. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2187 · Cited by 159
Targeting cancer with phosphodiesterase inhibitors
Savai, R., Pullamsetti, S. S., Banat, G.-A., Weißmann, N., Ghofrani, H. A., Grimminger, F., & SCHERMULY, R. T. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903485642 · Cited by 159
Cardioprotection with phosphodiesterase-5 inhibition—a novel preconditioning strategy
Kukreja, R. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.11.001 · Cited by 158
Pitari, G. M., Guglielmo, M. D. D., Park, J. Y., Schulz, S., & Waldman, S. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141124698 · Cited by 157
Phosphodiesterase Inhibitors in the Treatment of Inflammatory Diseases
Page, C. P., & Spina, D. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17969-3_17 · Cited by 156
Hansen, G., Jin, S.-L. C., Umetsu, D. T., & Conti, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6751 · Cited by 154
Cyclic GMP-Dependent Signaling in Cardiac Myocytes
Takimoto, E. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-0664 · Cited by 154
Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells
Timoshenko, A. V., Xu, G., Chakrabarti, S., Lala, P. K., & Chakraborty, C. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00269-6 · Cited by 153
Beca, S., Ahmad, F., Shen, W., Liu, J., Makary, S., Polidovitch, N., Sun, J., Hockman, S. C., Chung, Y. W., Movsesian, M. A., et al. (2012) · Circulation Research · doi:10.1161/circresaha.111.300003 · Cited by 150
Self-citationLeroy, J., Richter, W., Mika, D., Castro, L. R., Abi‐Gerges, A., Xie, M., Scheitrum, C., Lefebvre, F., Schittl, J., Matéo, P., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44747 · Cited by 149
Characterization of the First Potent and Selective PDE9 Inhibitor Using a cGMP Reporter Cell Line
Wunder, F., Tersteegen, A., Rebmann, A., Erb, C., Fahrig, T., & Hendrix, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.017608 · Cited by 149
Cloning and characterization of PDE7B, a cAMP-specific phosphodiesterase
Hetman, J., Soderling, S. H., Glavas, N. A., & Beavo, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.472 · Cited by 148
Reed, T. M., Repaske, D. R., Snyder, G. L., Greengard, P., & Vorhees, C. V. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-12-05188.2002 · Cited by 147
Cloning and characterization of mammalian homologs of the Drosophila dunce+ gene.
Davis, R., Takayasu, H., Eberwine, M., & Myres, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3604 · Cited by 146
Wong, M., Whelan, F., Deloukas, P., Whittaker, P., Delgado, M., Cantor, R. M., McCann, S. M., & Licinio, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602795103 · Cited by 145
Yuasa, K., Kotera, J., Fujishige, K., Michibata, H., Sasaki, T., & Omori, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003041200 · Cited by 145
Smith, P. G., Wang, F., Wilkinson, K., Savage, K. J. J., Klein, U., Neuberg, D. S., Bollag, G. E., Shipp, M. A., & Aguiar, R. C. T. (2004) · Blood · doi:10.1182/blood-2004-01-0240 · Cited by 144
TCR- and CD28-Mediated Recruitment of Phosphodiesterase 4 to Lipid Rafts Potentiates TCR Signaling
Abrahamsen, H., Baillie, G. S., Ngai, J., Vang, T., Nika, K., Ruppelt, A., Mustelin, T., Zaccolo, M., Houslay, M. D., & Taskén, K. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.8.4847 · Cited by 143
The Cardiac IKs Potassium Channel Macromolecular Complex Includes the Phosphodiesterase PDE4D3
Terrenoire, C., Houslay, M. D., Baillie, G. S., & Kass, R. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805366200 · Cited by 143
Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF
Pullamsetti, S. S., Banat, G. A., Schmall, A., Szibor, M., Pomagruk, D., Hänze, J., Kołosionek, E., Wilhelm, J., Braun, T. W., Grimminger, F., et al. (2012) · Oncogene · doi:10.1038/onc.2012.136 · Cited by 143
Tadalafil for the Treatment of Pulmonary Arterial Hypertension
Oudiz, R. J., Brundage, B. H., Galiè, N., Ghofrani, H. A., Simonneau, G., Botros, F. T., Chan, M., Beardsworth, A., & Barst, R. J. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.05.004 · Cited by 142
PDE4D plays a critical role in the control of airway smooth muscle contraction
Méhats, C., Jin, S.-L. C., Wahlstrom, J., Law, E. C., Umetsu, D. T., & Conti, M. (2003) · The FASEB Journal · doi:10.1096/fj.03-0274com · Cited by 142
Cyclic Adenosine Monophosphate Phosphodiesterase Type 4 Protects Against Atrial Arrhythmias
Molina, C. E., Leroy, J., Richter, W., Xie, M., Scheitrum, C., Lee, I.-O., Maack, C., Rücker‐Martin, C., Donzeau‐Gouge, P., Verde, I., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.01.060 · Cited by 142
Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD
Field, S. K. (2010) · Drug Design Development and Therapy · doi:10.2147/dddt.s7667 · Cited by 142
Isoforms of Cyclic Nucleotide Phosphodiesterase PDE3A in Cardiac Myocytes
Wechsler, J., Choi, Y. H., Krall, J., Ahmad, F., Manganiello, V. C., & Movsesian, M. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203647200 · Cited by 141
Self-citationZhang, H., Zhao, Y., Huang, Y., Dorairaj, N. R., Chandler, L. J., & O’Donnell, J. M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300440 · Cited by 141
Phosphodiesterase 8B Gene Variants Are Associated with Serum TSH Levels and Thyroid Function
Arnaud-Lopez, L., Usala, G., Ceresini, G., Mitchell, B. D., Pilia, M. G., Piras, M. G., Sestu, N., Maschio, A., Busonero, F., Albai, G., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.04.019 · Cited by 139
Ca2+-calmodulin-dependent phosphodiesterase (PDE1): Current perspectives
Goraya, T. A., & Cooper, D. M. F. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2004.12.017 · Cited by 139
Cyclic GMP as substrate and regulator of cyclic nucleotide phosphodiesterases (PDEs)
Juilfs, D. M., Soderling, S. H., Burns, F., & Beavo, J. A. (2005) · Springer eBooks · doi:10.1007/bfb0033670 · Cited by 137
Real-time Monitoring of the PDE2 Activity of Live Cells
Nikolaev, V. O., Gambaryan, S. P., Engelhardt, S. H., Walter, U., & Lohse, M. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400505200 · Cited by 137
Expression and regulation of human and rat phosphodiesterase type IV isogenes
Engels, P., Fichtel, K., & Lübbert, H. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00788-8 · Cited by 137
Exome Sequencing Identifies PDE4D Mutations in Acrodysostosis
Lee, H., Graham, J. M., Rimoin, D. L., Lachman, R. S., Krejčı́, P., Tompson, S. W. J., Nelson, S. F., Krakow, D., & Cohn, D. H. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.03.004 · Cited by 136
Hayashi, M., Matsushima, K., Ohashi, H., Tsunoda, H., Murase, S., Kawarada, Y., & Tanaka, T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9379 · Cited by 136
Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia
Nicholson, C. D. (1990) · Psychopharmacology · doi:10.1007/bf02244119 · Cited by 136
Seybold, J., Thomas, D., Witzenrath, M., Boral, Ş., Hocke, A. C., Bürger, A., Hatzelmann, A., Tenor, H., Schudt, C., Krüll, M., et al. (2005) · Blood · doi:10.1182/blood-2004-07-2729 · Cited by 135
EHT0202 in Alzheimers Disease: A 3-Month, Randomized, Placebo- Controlled, Double-Blind Study
Vellas, B., Sol, O., J. Snyder, P., Ousset, P.-J., Haddad, R., Maurin, M., Lemarie, J.-C., Desire, L., & P. Pando, M. (2011) · Current Alzheimer Research · doi:10.2174/156720511795256053 · Cited by 133
Exome Sequencing Identifies PDE4D Mutations as Another Cause of Acrodysostosis
Michot, C., Goff, C. L., Goldenberg, A., Abhyankar, A., Klein, C., Kinning, E., Guerrot, A., Flahaut, P., Duncombe, A., Baujat, G., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.03.003 · Cited by 133
Domek-Łopacińska, K., & Strosznajder, J. B. (2008) · Brain Research · doi:10.1016/j.brainres.2008.02.108 · Cited by 133
Beard, M., Olsen, A. E., Jones, R. E., Erdoğan, S., Houslay, M. D., & Bolger, G. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10349 · Cited by 132
Ubiquitous expression of phosphodiesterase 7A in human proinflammatory and immune cells
Smith, S. J., Brookes-Fazakerley, S., Donnelly, L., Barnes, P. J., Barnette, M. S., & Giembycz, M. A. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00170.2002 · Cited by 132
Dryja, T. P., Rucinski, D., Chen, S. H., & Berson, E. L. (1999) · PubMed · Cited by 131
From PDE3B to the regulation of energy homeostasis
Degerman, E., Ahmad, F., Chung, Y. W., Guirguis, E., Omar, B., Stenson, L., & Manganiello, V. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.09.015 · Cited by 130
Self-citationSonnenburg, W. K., Seger, D., Kwak, K. S., Huang, J., Charbonneau, H., & Beavo, J. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.30989 · Cited by 130
Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation
Essayan, D. M. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00331-1 · Cited by 129
Phosphodiesterase 11A (PDE11A) and Genetic Predisposition to Adrenocortical Tumors
Libé, R., Fratticci, A., Coste, J., Tissier, F., Horvath, A., Ragazzon, B., René-Corail, F., Groussin, L., BERTAGNA, X. Y., Raffin‐Sanson, M. L., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0106 · Cited by 129
Self-citationRivet, M., Vandecasteele, G., Hatem, S. N., Verde, I., Benardeau, A. M., Mercadier, J.-J., & Fischmeister, R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119460 · Cited by 129
Targeted Inhibition of Cyclic AMP Phosphodiesterase-4 Promotes Brain Tumor Regression
Goldhoff, P., Warrington, N. M., Limbrick, D. D., Hope, A. J., Woerner, B. M., Jackson, E. N., Perry, A., Piwnica-Worms, D. R., & Rubin, J. B. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0827 · Cited by 129
Cyclic GMP and Nitric Oxide Synthase in Aging and Alzheimer's Disease
Domek-Łopacińska, K., & Strosznajder, J. B. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8104-x · Cited by 127
Stevens, J., Simpson, E. L., Harnan, S., Squires, H., Meng, Y., Thomas, S., Michaels, J. A., & Stansby, G. P. (2012) · British journal of surgery · doi:10.1002/bjs.8895 · Cited by 127
Cited by
Herrmann, F. E., Hesslinger, C., Wollin, L., & Nickolaus, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.838449 · Cited by 137
Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis
Kolb, M., Crestani, B., & Maher, T. M. (2023) · European Respiratory Review · doi:10.1183/16000617.0206-2022 · Cited by 85
Muo, I. M., MacDonald, S. D., Madan, R., Park, S.-J., Gharib, A. M., Martinez, P. E., Walter, M. F., Yang, S. B., Rodante, J. A., Courville, A. B., et al. (2019) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s182953 · Cited by 21
Metadata
- Authors
- Azevedo, M. F., Faucz, F. R., Bimpaki, E., Horvath, A., Levy, I., de Alexandre, R. B., Ahmad, F., Manganiello, V., & Stratakis, C. A.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2013-12-05
- Volume
- 35
- Issue
- 2
- Pages
- 195-233
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2087208986
- Cited by
- 325
- References
- 381
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.